- 专利标题： 4,5-annulated 1,2,4-triazolones
-
申请号： US17161615申请日： 2021-01-28
-
公开(公告)号： US11787797B2公开(公告)日： 2023-10-17
- 发明人: Stefan Nikolaus Gradl , Duy Nguyen , Knut Eis , Judith Günther , Timo Stellfeld , Andreas Janzer , Sven Christian , Thomas Mueller , Sherif El Sheikh , Han Jie Zhou , Changjia Zhao , David B. Sykes , Steven James Ferrara , Kery Liu , Simon Anthony Herbert , Claudia Merz , Michael Niehues , Carl Friedrich Nising , Martina Schäfer , Katja Zimmermann , Jörg Knäblein , Kai Thede , Thomas Faupel
- 申请人： BAYER AKTIENGESELLSCHAFT , BAYER PHARMA AKTIENGESELLSCHAFT , THE BROAD INSTITUTE, INC. , PRESIDENT AND FELLOWS OF HARVARD COLLEGE , THE GENERAL HOSPITAL CORPORATION
- 申请人地址： DE MA Leverkusen
- 专利权人： BAYER AKTIENGESELLSCHAFT,BAYER PHARMA AKTIENGESELLSCHAFT,THE BROAD INSTITUTE, INC.,PRESIDENT AND FELLOWS OF HARVARD COLLEGE,THE GENERAL HOSPITAL CORPORATION
- 当前专利权人： BAYER AKTIENGESELLSCHAFT,BAYER PHARMA AKTIENGESELLSCHAFT,THE BROAD INSTITUTE, INC.,PRESIDENT AND FELLOWS OF HARVARD COLLEGE,THE GENERAL HOSPITAL CORPORATION
- 当前专利权人地址： DE Leverkusen; DE Berlin; US MA Cambridge; US MA Cambridge; US MA Boston
- 代理机构： Greenberg Traurig, LLP
- 代理商 Melissa Hunter-Ensor; Scott Goncher
- 分案原申请号： US16345178
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61P35/00 ; C07D487/04 ; C07D498/04 ; C07D513/04 ; C07D519/00 ; C12N1/20 ; C12P17/18
摘要：
The present invention provides triazolone compounds of general formula (I):
in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
公开/授权文献
- US20210188846A1 4,5-ANNULATED 1,2,4-TRIAZOLONES 公开/授权日：2021-06-24
信息查询
